Lynn Baxter

Lynn Baxter
Lynn Baxter | CEO, ViiV Healthcare and President, Global Health, GSK

Lynn Baxter was appointed CEO of ViiV Healthcare and President of Global Health, GSK, effective 1 November 2026.

Lynn joined GSK in 2009 and has held various senior commercial operational and strategic leadership roles across Europe, Asia Pacific, and Emerging Markets. Before her current appointment, she served as President, Europe, where she was responsible for the commercial performance and strategic direction of GSK’s European markets across more than 30 countries. Her previous roles also include SVP Head of Global Product Strategy for Vaccines and SVP Head of North America at ViiV Healthcare.

Before joining GSK, Lynn held commercial roles of increasing seniority at Roche and Merck & Co.

She is a Board member of the Royal Edinburgh Military Tattoo.

Lynn holds a Bachelor’s degree from the University of Strathclyde.